Update on Janus Kinase Antagonists in Inflammatory Bowel Disease

被引：69

作者：

Boland, Brigid S. ^{[1
,2
]}

Sandborn, William J. ^{[1
,2
]}

Chang, John T. ^{[1
,2
]}

机构：

[1] Univ Calif San Diego, Div Gastroenterol, Dept Med, Ctr Inflammatory Bowel Dis, La Jolla, CA 92093 USA

[2] Univ Calif San Diego, Digest Dis Res Dev Ctr, La Jolla, CA 92093 USA

来源：

GASTROENTEROLOGY CLINICS OF NORTH AMERICA | 2014年 / 43卷 / 03期

关键词：

Janus kinase inhibitors; Small-molecule therapy; Tofacitinib; Inflammatory bowel disease; Ulcerative colitis; Crohn disease; B-CELL FUNCTION; CROHNS-DISEASE; RHEUMATOID-ARTHRITIS; INHIBITOR; TOFACITINIB; PLACEBO; JAK2; IMMUNODEFICIENCY; INCB018424; ACTIVATION;

D O I：

10.1016/j.gtc.2014.05.011

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Janus kinase (JAK) inhibitors have emerged as a novel orally administered small-molecule therapy for the treatment of ulcerative colitis and possibly Crohn disease. These molecules are designed to selectively target the activity of specific JAKs and to offer a targeted mechanism of action without risk of immunogenicity. Based on data from clinical trials in rheumatoid arthritis and phase 2 studies in inflammatory bowel disease, tofacitinib and other JAK inhibitors are likely to become a new form of medical therapy for the treatment of inflammatory bowel disease.

引用

页码：603 / +

页数：16

共 51 条

[1] MECHANISMS OF DISEASE Inflammatory Bowel Disease [J].

Abraham, Clara ;

Cho, Judy H. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (21) :2066-2078

[2]

[Anonymous], 2012, TOF TREATM RHEUM ART

[3]

[Anonymous], CLIN GASTROENTEROL H

[4] Crohn's disease [J].

Baumgart, Daniel C. ;

Sandborn, William J. .

LANCET, 2012, 380 (9853) :1590-1605

[5] B-cell function in severe combined immunodeficiency after stem cell or gene therapy: A review [J].

Buckley, Rebecca H. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (04) :790-797

[6] Inborn Errors of Human JAKs and STATs [J].

Casanova, Jean-Laurent ;

Holland, Steven M. ;

Notarangelo, Luigi D. .

IMMUNITY, 2012, 36 (04) :515-528

[7] CORRELATIONS BETWEEN CLINICAL ACTIVITY, ENDOSCOPIC SEVERITY, AND BIOLOGICAL PARAMETERS IN COLONIC OR ILEOCOLONIC CROHNS-DISEASE - A PROSPECTIVE MULTICENTER STUDY OF 121 CASES [J].

CELLIER, C ;

SAHMOUD, T ;

FROGUEL, E ;

ADENIS, A ;

BELAICHE, J ;

BRETAGNE, JF ;

FLORENT, C ;

BOUVRY, M ;

MARY, JY ;

MODIGLIANI, R ;

COLOMBEL, JF ;

CORTOT, A ;

LESCUT, D ;

BITOUN, A ;

LEMANN, M ;

SALMERON, M ;

THEROND, JP ;

VERNISSE, B ;

SEE, A ;

RAOUL, JL .

GUT, 1994, 35 (02) :231-235

[8] Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor [J].

Changelian, PS ;

Flanagan, ME ;

Ball, DJ ;

Kent, CR ;

Magnuson, KS ;

Martin, WH ;

Rizzuti, BJ ;

Sawyer, PS ;

Perry, BD ;

Brissette, WH ;

McCurdy, SP ;

Kudlacz, EM ;

Conklyn, MJ ;

Elliott, EA ;

Koslov, ER ;

Fisher, MB ;

Strelevitz, TJ ;

Yoon, K ;

Whipple, DA ;

Sun, JM ;

Munchhof, MJ ;

Doty, JL ;

Casavant, JM ;

Blumenkopf, TA ;

Hines, M ;

Brown, MF ;

Lillie, BM ;

Subramanyam, C ;

Shang-Poa, C ;

Milici, AJ ;

Beckius, GE ;

Moyer, JD ;

Su, CY ;

Woodworth, TG ;

Gaweco, AS ;

Beals, CR ;

Littman, BH ;

Fisher, DA ;

Smith, JF ;

Zagouras, P ;

Magna, HA ;

Saltarelli, MJ ;

Johnson, KS ;

Nelms, LF ;

Des Etages, SG ;

Hayes, LS ;

Kawabata, TT ;

Finco-Kent, D ;

Baker, DL ;

Larson, M .

SCIENCE, 2003, 302 (5646) :875-878

[9] Genomics and the Multifactorial Nature of Human Autoimmune Disease [J].

Cho, Judy H. ;

Gregersen, Peter K. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (17) :1612-1623

[10] MEDICAL PROGRESS Ulcerative Colitis [J].

Danese, Silvio ;

Fiocchi, Claudio .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (18) :1713-1725

← 1 2 3 4 5 6 →